Neumora Therapeutics (NMRA) Stock Crashes by 21.97% on October 2nd, 2023

Neumora Therapeutics(NMRA) Stock Analysis

Neumora Therapeutics, a renowned player in the Biopharmaceutical industry, witnessed notable activity in its share price on October 2nd, 2023. The trading day commenced with an opening price of $14.40 USD, setting the stage for a day of market dynamics. Despite encountering fluctuations throughout the day, the stock ultimately settled at $11.01 USD at the closing bell, reflecting a decrease of $3.10 USD (21.97%) compared to the previous day's closing price. The after-hours trading session exhibited minimal change, with the stock maintaining its value at $11.30 USD.

Investors closely observed the day's price range, with the stock reaching a high of $14.78 USD and a low of $10.70 USD, offering insights into the volatility of the market. Additionally, the 52-week performance metrics reveal a 52-week high of $17.74 USD and a 52-week low of $9.90 USD, illustrating the stock's historical price range over the past year.

This data provides a snapshot of Neumora Therapeutics's stock performance on October 2nd, 2023, shedding light on the day's price movements and the stock's broader performance over the last year. It serves as valuable information for investors and market analysts to assess the company's standing and make informed investment decisions in the ever-evolving Biopharmaceutical sector.

Key Metrics

• Opening Price: $14.40 USD
• Closing Price: $11.01 USD
• After Hours Price: $11.30 USD
• Market Capitalization: 1.67B USD

Price Range Today

• High: $$14.78 USD
• Low: $10.70 USD

52-Week Performance

• 52-Week High: $17.74 USD
• 52-Week Low: $9.90 USD